An Allentown company, U.S. Specialty Formulations, is developing a new oral COVID-19 vaccine that promises to expand the number of people vaccinated around the world. The vaccine is undergoing clinical trials now. Grover Silcox reports.
Read More
An Allentown company, U.S. Specialty Formulations, is developing a new oral COVID-19 vaccine that promises to expand the number of people vaccinated around the world. The vaccine is undergoing clinical trials now. Grover Silcox reports.
Read MoreWritten by
Specializing in pharmaceutical manufacturing, regulatory‑compliant digital marketing, and healthcare industry growth strategies. This multidisciplinary team provides subject‑matter expertise relevant to USSF’s cGMP operations, botanical injectables, and clinical education initiatives.